The impact of two semiannual treatments with albendazole alone on lymphatic filariasis and soil-transmitted helminth infections: a community-based study in the Republic of Congo

The American Journal of Tropical Medicine and Hygiene
Sébastien D PionFrançois Missamou

Abstract

Implementation of mass drug administration (MDA) with ivermectin plus albendazole (ALB) for lymphatic filariasis (LF) has been delayed in central Africa because of the risk of serious adverse events in subjects with high Loa loa microfilaremia. We conducted a community trial to assess the impact of semiannual MDA with ALB (400 mg) alone on LF and soil-transmitted helminth (STH) infections in the Republic of Congo. Evaluation at 12 months showed that ALB MDA had not significantly reduced Wuchereria bancrofti antigenemia or microfilaria (mf) rates in the community (from 17.3% to 16.6% and from 5.3% to 4.2%, respectively). However, the geometric mean mf count in mf-positive subjects was reduced from 202.2 to 80.9 mf/mL (60% reduction, P = 0.01). The effect of ALB was impressive in 38 subjects who were mf-positive at baseline and retested at 12 months: 37% had total mf clearance, and individual mf densities were reduced by 73.0%. MDA also dramatically reduced the hookworm infection rate in the community from 6.5% to 0.6% (91% reduction), with less impressive effects on Ascaris and Trichuris. These preliminary results suggest that semiannual community MDA with ALB is a promising strategy for controlling LF and STH in areas with coen...Continue Reading

References

Jul 1, 1993·The Journal of Infectious Diseases·A D KlionT B Nutman
Aug 6, 1998·Transactions of the Royal Society of Tropical Medicine and Hygiene·M M IsmailA S Dissanaike
Aug 9, 2001·Transactions of the Royal Society of Tropical Medicine and Hygiene·M M IsmailW K Balasooriya
Sep 2, 2005·Tropical Medicine & International Health : TM & IH·Julia CritchleyUNKNOWN International Filariasis Review Group
Jun 1, 2006·Advances in Parasitology·Eric A Ottesen
Oct 9, 2008·PLoS Neglected Tropical Diseases·Eric A OttesenGautam Biswas
Sep 18, 2010·Current Opinion in Infectious Diseases·Moses J Bockarie, Rinki M Deb
Nov 3, 2010·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Benoit DembeleAmy D Klion
Nov 3, 2010·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·James W Kazura
Nov 11, 2010·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Stefanie KnoppJürg Utzinger
Mar 6, 2013·The American Journal of Tropical Medicine and Hygiene·Aïssatou DiawaraRoger K Prichard
Sep 11, 2013·The American Journal of Tropical Medicine and Hygiene·Cédric B ChesnaisMichel Boussinesq
Dec 1, 2011·International Journal for Parasitology. Drugs and Drug Resistance·Jozef VercruysseBruno Levecke
May 14, 2014·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Roy AndersonT Deirdre Hollingsworth
Jun 12, 2014·Parasites & Vectors·James E TruscottRoy M Anderson

❮ Previous
Next ❯

Citations

Nov 10, 2015·Current Tropical Medicine Reports·Poppy H L Lamberton, Peter M Jourdan
Oct 4, 2016·International Journal for Parasitology. Drugs and Drug Resistance·Annette C Kuesel
Jul 9, 2016·Infectious Diseases of Poverty·Hugo C TurnerMark H Bradley
May 28, 2016·The Journal of Infectious Diseases·Cédric B ChesnaisMichel Boussinesq
Apr 27, 2016·The American Journal of Tropical Medicine and Hygiene·Cédric B ChesnaisMichel Boussinesq
Oct 28, 2015·The American Journal of Tropical Medicine and Hygiene·Gregory S NolandManuel Gonzalez
Sep 12, 2017·PLoS Neglected Tropical Diseases·Cédric B ChesnaisGary J Weil
Jan 9, 2019·The Cochrane Database of Systematic Reviews·Cara L MacfarlanePaul Garner
Apr 2, 2020·The American Journal of Tropical Medicine and Hygiene·Abel EigegeFrank O Richards
Oct 29, 2017·Proceedings of the National Academy of Sciences of the United States of America·Joseph D TurnerMark J Taylor
Apr 11, 2018·Infection & chemotherapy·Sung Tae Hong
Jul 16, 2020·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Chandni PatelJennifer Keiser
Apr 2, 2016·Enfermedades infecciosas y microbiología clínica·Núria Serre-DelcorUNKNOWN Grupo de trabajo de +REDIVI

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Ascariasis (ASM)

Ascariasis is a helminthic infection of global distribution with more than 1.4 billion persons infected throughout the world. Here is the latest research.

Ascariasis

Ascariasis is a helminthic infection of global distribution with more than 1.4 billion persons infected throughout the world. Here is the latest research.

Anthelmintics (ASM)

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.